<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1108987</article-id><article-id pub-id-type="publisher-id">OALibJ-119007</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Barrier of Hypertensive Drugs among Patients in Tanzania: Case Study of Southern Highlands, Tanzania
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Harun</surname><given-names>Elmada Nyagori</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bethsheba</surname><given-names>L. Sakinoi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Jakaya Kikwete Cardiac Institute, Dar es Salaam, Tanzania</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>08</month><year>2022</year></pub-date><volume>09</volume><issue>08</issue><fpage>1</fpage><lpage>7</lpage><history><date date-type="received"><day>11,</day>	<month>June</month>	<year>2022</year></date><date date-type="rev-recd"><day>30,</day>	<month>July</month>	<year>2022</year>	</date><date date-type="accepted"><day>3,</day>	<month>August</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Experience with patients shows that prescribed drugs for treating hypertension disease fail to work effectively, causing high mortality rates in African Ethnic types. This situation has resulted in the query as to why the situation exists. The study was conducted to investigate factors affecting the failure of hyper-tension drugs among patients suffering from the disease. Particularly, the study aimed at examining cultural, individual and financial factors affecting drug failure among Tanzania patients. The sample consisted of 300 respondents from Afya Medicare Specialized Clinic and Mbeya Referral hospital in Tan-zania. Questionnaires were distributed and interviews were conducted with pa-tients and their caretakers, doctors and nurses in both health centres. The study revealed that the drugs fail to provide relief to the patients because of the neg-ative attitude towards the consumption of the drugs in the belief that the dis-eases affected only rich people and developed countries. From the findings, it was concluded that education should be provided to the patients as well as their caretakers on the fact that the disease can affect anyone and emphasize preventive measures.
 
</p></abstract><kwd-group><kwd>Barrier</kwd><kwd> Hypertensive Drugs</kwd><kwd> Mortality</kwd><kwd> Cultural Factors</kwd><kwd> Tanzania</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hypertension is a form of cardiovascular disorder that results from a wide range of inter-connected ontologies. Untreated and uncontrolled hypertension leads to structural and functional abnormalities of cardiovascular system, which ultimately harm the vital organs of body, e.g. heart, failure and chronic kidney diseases [<xref ref-type="bibr" rid="scirp.119007-ref1">1</xref>] . The experience with patients shows that prescribed drugs for treating hypertension diseases fail to work effectively, causing high mortality rates in African Ethic types. Whereas this situation has resulted in the query as to why the situation exists [<xref ref-type="bibr" rid="scirp.119007-ref2">2</xref>] . The study was conducted to investigate factors affecting the failure of hypertension drugs among patients suffering from the disease. Particularly, the study aimed at examining cultural, individual and financial factors affecting drug failure among Tanzania patients.</p></sec><sec id="s2"><title>2. Methods</title><p>Cross-sectional descriptive comparative study was utilized, the study was conducted in two different hospitals in Mbeya and Njombe regions, which are Afya Medicare specialized clinic and Mbeya Referral Hospital in Tanzania. And 300 patients were recruited from the all two medical out patients general clinics of Afya Medicare specialized clinic and Mbeya Referral hospital. The eligible respondents were selected by systematic randomized controlled sampling method. The study was conducted for a period of 4 months from August to November 2021.</p><sec id="s2_1"><title>2.1. Study Area</title><p>The study was conducted in two different hospitals in Mbeya and Njombe regions, which are Afya Medicare specialized clinic and Mbeya Regional Referral Hospital in Tanzania.</p></sec><sec id="s2_2"><title>2.2. Sample Size</title><p>Three hundred (300) patients were recruited from the all two medical out patients general clinics of Afya Medicare specialized clinic and Mbeya Regional Referral hospital.</p></sec><sec id="s2_3"><title>2.3. Sampling Methods</title><p>The eligible respondents were selected by systematic randomized controlled sampling method.</p></sec><sec id="s2_4"><title>2.4. Study Period</title><p>The study was conducted for a period of 4 months from July to November 2021.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The demographic and clinical characteristics of the 300 individuals, who were identified at the study site, are as described below:-</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows the Gender of individuals with hypertension in interviewed in the study, according to the data observed, 51.3% of individuals were female and 48.7% were male. This implies that most of women especially in the southern highland s of Tanzania are Hypertension case, and this may be due to the lifestyle around the area.</p><p><xref ref-type="table" rid="table2">Table 2</xref> shows the frequency at which patients forget the intake of their medications, according to the observed data, 62.3% of individuals forget to take their medications on time and others forget completely to take the medication either purposely or unintended, and 37.7% do not forget their medications. The results imply that most of patients with hypertension fail to improve due to resistance of taking their medications as required and instructed. The graph (<xref ref-type="fig" rid="fig1">Figure 1</xref>) below illustrates more details.</p><p><xref ref-type="table" rid="table3">Table 3</xref> indicates the frequency of medication intake within the past two weeks where by 56.7% shows that most of the patients didn’t follow the medications as they were prescribed with their medical personnel, and 43.3% shows that they did not forget taking their medications in the past two weeks, these results imply that most of patients hate following the given procedures.</p><p><xref ref-type="table" rid="table4">Table 4</xref> indicates the frequency at which the patient has ever stopped or taken medication without consulting the doctor, whereby 62.0% of the interviewed individuals shows that they stopped medications without telling their medical instructors and 36.0% shows that they follow the instructions very well. These results imply that a high number of individuals with hypertension have resistance to medications due to ignorance and other factors such as social issues and lifestyle.</p><p><xref ref-type="table" rid="table5">Table 5</xref> shows that 52.3% of people when they travel or leave home they sometimes forget to take their medications with them, and 47.7% of people</p>


<table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Gender</title></caption>
</table-wrap></sec></body>
<back><ref-list><title>References</title><ref id="scirp.119007-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Elliott, W.J. (2003) The Economic Impact of Hypertension. Journal of Clinical Hyper-tension, 5, 1-13. https://doi.org/10.1111/j.1524-6175.2003.02463.x</mixed-citation></ref><ref id="scirp.119007-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Australian Federal Government. Australian Institute of Health and Welfare. High Blood Pressure. http://www.aihw.gov.au/high-blood-pressure/</mixed-citation></ref><ref id="scirp.119007-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Whelton, P.K. et al. (2002) Primary Prevention of Hypertension: Clinical and Public Health Advisory from the National High Blood Pressure Education Program. Journal of the American Medical Association, 288, 1882-1888.  
https://doi.org/10.1001/jama.288.15.1882</mixed-citation></ref><ref id="scirp.119007-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Stevens, V., et al. (1993) Weight Loss Intervention in Phase 1 of the Trials of Hyper-tension Prevention. Archives of Internal Medicine, 153, 849-858. 
http://archinte.ama-assn.org/cgi/content/abstract/153/7/849 
&lt;br /&gt;https://doi.org/10.1001/archinte.1993.00410070039006</mixed-citation></ref><ref id="scirp.119007-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chockalingam, A. (2007) Impact of World Hypertension Day. The Canadian Journal of Cardiology, 23, 517-519. https://doi.org/10.1016/S0828-282X(07)70795-X</mixed-citation></ref><ref id="scirp.119007-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">American Heart Foundation (2000) Resistance Exercise in Individuals with and without Cardiovascular Disease: Benefits, Rationale, Safety, and Prescription—An Advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology. Circulation, 101, 828-833. 
http://circ.ahajournals.org/content/101/7/828/T1.expansion.html 
&lt;br /&gt;https://doi.org/10.1161/01.CIR.101.7.828</mixed-citation></ref><ref id="scirp.119007-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Sorace, P., et al. (2009) Hypertension and Resistance Training. Strength and Condi-tioning Journal, 31, 33-35. https://doi.org/10.1519/SSC.0b013e318195bb29  
http://www.cross-fitllc.com/wp-content/uploads/2010/06/Hypertension-and-Resistance-Training.pdf</mixed-citation></ref><ref id="scirp.119007-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Cornelissen, V.A. and Fagard, R.H. (2005) Effects of Endurance Training on Blood Pressure, Blood Pressure—Regulating Mechanisms, and Cardiovascular Risk Factors. Hypertension, 46, 667-675. http://hyper.ahajournals.org/content/46/4/667.full 
https://doi.org/10.1161/01.HYP.0000184225.05629.51</mixed-citation></ref><ref id="scirp.119007-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">American College of Sports Medicine (2009) ACSM’s Guidelines for Exercise Testing and Prescription. Lippincott Williams &amp; Wilkins, Philadelphia.</mixed-citation></ref><ref id="scirp.119007-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Hypertension/High Blood Pressure Health Center. Exercise Tips for Those with High Blood Pressure.  
http://www.webmd.com/hypertension-high-blood-pressure/guide/safe-exercise-tips</mixed-citation></ref><ref id="scirp.119007-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Fagard, R.H. (1999) Physical Activity in the Prevention and Treatment of Hypertension in the Obese. Medicine &amp; Science in Sports &amp; Exercise, 31, s624.  
https://doi.org/10.1097/00005768-199911001-00022</mixed-citation></ref><ref id="scirp.119007-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Lewis, S.P. (2013) The NICE Hypertension Guideline Update 2006: A Welcome Revi-sion. British Journal of Hospital Medicine, 67, 454-455.  
https://doi.org/10.12968/hmed.2006.67.Sup9.21995</mixed-citation></ref><ref id="scirp.119007-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Arguedas, J.A., Leiva, V. and Wright, J.M. (2020) Blood Pressure Targets in Adults with Hypertension. The Cochrane Database of Systematic Reviews, 12, Article ID: CD004349. https://doi.org/10.1002/14651858.CD004349.pub3</mixed-citation></ref><ref id="scirp.119007-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Qaseem, A., Wilt, T.J., Rich, R., Humphrey, L.L., Frost, J. and Forciea, M.A. (2017) Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline from the Ameri-can College of Physicians and the American Academy of Family Physicians. Annals of Internal Medicine, 166, 430-437. https://doi.org/10.7326/M16-1785</mixed-citation></ref></ref-list></back></article>